ID   B4BC CL
AC   CVCL_E7HS
RX   PubMed=37344100;
CC   Characteristics: Tumorigenic. Will induce tumors when injected subcutaneously in the mammary fat pad of immunocompetent tumor-naive C57BL/6 mice (PubMed=37344100).
CC   Transformant: ChEBI; CHEBI_6716; Medroxyprogesterone acetate (MPA).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E7HQ ! B2BC CL
OI   CVCL_E7HR ! B3BC CL
SX   Female
AG   13-16W
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   PubMed=37344100; DOI=10.1136/jitc-2023-007117; PMCID=PMC10314679;
RA   Perez-Lanzon, Maria
RA   Carbonnier, Vincent
RA   Cordier, Pierre
RA   De Palma, Fatima Domenica Elisa
RA   Petrazzuolo, Adriana
RA   Klein, Christophe
RA   Arbaretaz, Floriane
RA   Mangane, Khady
RA   Stoll, Gautier
RA   Martins, Isabelle
RA   Fohrer-Ting, Helene
RA   Paillet, Juliette
RA   Mouillet-Richard, Sophie
RA   Le Corre, Delphine
RA   Xiao, Wen-Jin
RA   Sroussi, Marine
RA   Desdouets, Chantal
RA   Laurent-Puig, Pierre
RA   Pol, Jonathan G.
RA   Lopez-Otin, Carlos
RA   Maiuri, Maria Chiara
RA   Kroemer, Guido
RT   "New hormone receptor-positive breast cancer mouse cell line mimicking
RT   the immune microenvironment of anti-PD-1 resistant mammary carcinoma.";
RL   J. Immunother. Cancer 11:e007117.1-e007117.17(2023).
//